-- Novel discovery improves the immunological activity of certain cancer fighting antibodies
-- Agenus' next generation anti-CTLA-4 antibody (AGEN1181) developed using this technology is slated for IND in 2018
PR Newswire
LEXINGTON, Mass., June 12, 2018